Form 8-K - Current report:
SEC Accession No. 0001104659-25-122555
Filing Date
2025-12-18
Accepted
2025-12-18 16:20:42
Documents
12
Period of Report
2025-12-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2533712d1_8k.htm   iXBRL 8-K 28857
  Complete submission text file 0001104659-25-122555.txt   195207

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cgtx-20251216.xsd EX-101.SCH 3005
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgtx-20251216_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgtx-20251216_pre.xml EX-101.PRE 22352
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2533712d1_8k_htm.xml XML 3693
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2500 WESTCHESTER AVE PURCHASE NY 10577 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40886 | Film No.: 251583348
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)